Dabigatran Etexilate
NDC 67877-475, Dabigatran Etexilate, capsule, coated pellets, from Ascend Laboratories, LLC.
- Product NDC
- 67877-475
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- CAPSULE, COATED PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208040
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DABIGATRAN ETEXILATE MESYLATE150 mg/1
Pharmacologic classes
Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-475-60 | 67877047560 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-475-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3a8ec82a-c367-40dc-9302-e1896fcb05eaNADAC price for package 67877047560
GET /v1/drugs/nadac/67877047560
Use it
Look up 67877-475 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-475. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.